Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Electronics Production | February 16, 2007

Cepheid acquires Sangtec for $27M

Cepheid a broad-based molecular diagnostics company has acquired Sangtec Molecular Diagnostics AB for about $27 million.
Sangtec is based in Bromma, Sweden, the company develops and manufactures PCR-based molecular diagnostics products. Sangtec has 59 employees and reported revenue in 2006 of about $8 million. Cepheid plans to integrate the Sangtec diagnostic kits targeted at the immunocompromised market into its existing European and U.S. portfolio of in vitro diagnostic products.

Comments

Please note the following: Critical comments are allowed and even encouraged. Discussions are welcome. Verbal abuse, insults and racist / homophobic remarks are not. Such comments will be removed.
Further details can be found here.
Ad
Ad
Ad
Ad
Load more news
November 14 2017 8:30 PM V8.8.9-1